2Pedersen T, Olsson AG, Faergeman O. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the scandinavian simvastatin survival study. Circulation, 1998,97(15) : 1453. 被引量：1
3The Lipid Study Group.Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998,339(19) : 1349. 被引量：1
4Roberto Corti,MD, et al. Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions. Circulation,2002,2(1) :11. 被引量：1
7Pedersen T, Olsson AG, Faergeman O. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the scandinavian simvastatin survival study [J] . Circulation, 1998, 97 (15): 1453. 被引量：1
8The Lipid Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels [J] . N Engl J Med, 1998, 339 (19):1349. 被引量：1
9Pitt B, Waters D, Brown WV, et al. Aggressive lipid - lowering therapy compared with angioplasty in stable coronary artery disease[J]. N Engl J Med, 1999,341:70. 被引量：1
